Orange Book product · Generic (ANDA)
TAMOXIFEN CITRATE
TAMOXIFEN CITRATE
At a glance
Feb 20, 2003
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 20, 2003
23 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
TAMOXIFEN CITRATE
Strength
EQ 10MG BASE
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 076179
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of TAMOXIFEN CITRATE
- 2005SOLTAMOXBrand (NDA)
NDA 021807 · MAYNE PHARMA COMMRCL
- —NOLVADEXBrand (NDA)
NDA 017970 · ASTRAZENECA
- 2020TAMOXIFEN CITRATEGeneric (ANDA)
ANDA 213358 · EUGIA PHARMA
- 2017TAMOXIFEN CITRATEGeneric (ANDA)
ANDA 206694 · ZYDUS PHARMS
- 2011TAMOXIFEN CITRATEGeneric (ANDA)
ANDA 090878 · APOTEX
- 2003TAMOXIFEN CITRATEGeneric (ANDA)
ANDA 074504 · TEVA
- 2003TAMOXIFEN CITRATEGeneric (ANDA)
ANDA 076398 · AEGIS PHARMS
- 2003TAMOXIFEN CITRATEGeneric (ANDA)
ANDA 074539 · PHARMACHEMIE
- 2003TAMOXIFEN CITRATEGeneric (ANDA)
ANDA 070929 · ACTAVIS LABS FL INC
- 2003TAMOXIFEN CITRATEGeneric (ANDA)
ANDA 075797 · DR REDDYS LABS SA
- 2003TAMOXIFEN CITRATEGeneric (ANDA)
ANDA 075740 · IVAX SUB TEVA PHARMS
- 2003TAMOXIFEN CITRATEGeneric (ANDA)
ANDA 074732 · MYLAN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
